{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:17Z","timestamp":1790677397526,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD18\/00195"],"award-info":[{"award-number":["CD18\/00195"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/1525"],"award-info":[{"award-number":["PI18\/1525"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021566","name":"Fundaci\u00f3n Isabel Gemio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajpath.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T23:42:11Z","timestamp":1653090131000},"page":"1151-1166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-8162","authenticated-orcid":false,"given":"Ana","family":"Carrasco-Rozas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Fern\u00e1ndez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pi\u00f1ol-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alonso-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"de Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-3837","authenticated-orcid":false,"given":"Peter","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Hern\u00e1ndez-La\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-2236","authenticated-orcid":false,"given":"Carmen","family":"Paradas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"D\u00edaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2022.05.003_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2022.05.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ajpath.2022.05.003_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ajpath.2022.05.003_bib4","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41436-019-0527-9","article-title":"Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ajpath.2022.05.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: clinical spectrum and genotype in 31 patients","volume":"11","author":"Van Capelle","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajpath.2022.05.003_bib6","first-page":"82","article-title":"Clinical features of Pompe disease","volume":"32","author":"Manganelli","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","volume":"160C","author":"Sch\u00fcller","year":"2012","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajpath.2022.05.003_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","article-title":"Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy","volume":"9","author":"Katzin","year":"2008","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ajpath.2022.05.003_bib9","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2022.05.003_bib10","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s00415-021-10409-9","article-title":"STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa","volume":"268","author":"Gutschmidt","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/nan.12580","article-title":"An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease","volume":"46","author":"Kulessa","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nmd.2016.10.010","article-title":"Quantification of muscle pathology in infantile Pompe disease","volume":"27","author":"Sch\u00e4nzer","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2022.05.003_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","article-title":"Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy","volume":"101","author":"Raben","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajpath.2022.05.003_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","article-title":"Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited","volume":"33","author":"Schoser","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12035-019-01820-5","article-title":"Molecular approaches for the treatment of Pompe disease","volume":"57","author":"Bellotti","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4161\/auto.21691","article-title":"Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients","volume":"8","author":"Nascimbeni","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ajpath.2022.05.003_bib17","first-page":"42","article-title":"Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)","volume":"38","author":"Ripolone","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib18","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/cdd.2012.52","article-title":"The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)","volume":"19","author":"Nascimbeni","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2022.05.003_bib19","series-title":"Muscle Biopsy: A Practical Approach","author":"Dubowitz","year":"2013"},{"key":"10.1016\/j.ajpath.2022.05.003_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ajpath.2022.05.003_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.25.1.58","article-title":"A new program for investigating adult human skeletal muscle grown aneurally in tissue culture","volume":"25","author":"Askanas","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2022.05.003_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2044-5040-1-34","article-title":"Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders","volume":"1","author":"Mamchaoui","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.ajpath.2022.05.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09309-8","article-title":"Hypoxia triggers IFN-I production in muscle: implications in dermatomyositis","volume":"7","author":"De Luna","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2022.05.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Su\u00e1rez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajpath.2022.05.003_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2020.02.024","article-title":"Bnip3 in mitophagy: novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction","volume":"506","author":"Gao","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpath.2022.05.003_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2022.05.003_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.15252\/emmm.201606547","article-title":"Modulation of mTOR signaling as a strategy for the treatment of Pompe disease","volume":"9","author":"Lim","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2022.05.003_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4161\/auto.7.6.15123","article-title":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR","volume":"7","author":"Egan","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.ajpath.2022.05.003_bib30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.yjmcc.2009.12.004","article-title":"Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism","volume":"48","author":"Quinsay","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrm2434","article-title":"Cytochrome c: functions beyond respiration","volume":"9","author":"Ow","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ncb2422","article-title":"Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells","volume":"14","author":"Liu","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40478-018-0620-3","article-title":"Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease","volume":"6","author":"Schaaf","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ajpath.2022.05.003_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4161\/auto.4591","article-title":"Deconstructing Pompe disease by analyzing single muscle fibers: \u201cto see a world in a grain of sand...\u201d","volume":"3","author":"Raben","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.ajpath.2022.05.003_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder - murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ajpath.2022.05.003_bib36","first-page":"1704","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Am Assoc Adv Sci"},{"key":"10.1016\/j.ajpath.2022.05.003_bib37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2006010083","article-title":"Protein degradation by the ubiquitin-proteasome pathway in normal and disease states","volume":"17","author":"Lecker","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib38","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00134-014-3224-9","article-title":"Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness","volume":"40","author":"Wollersheim","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajpath.2022.05.003_bib39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/bpa.12864","article-title":"Differential diagnosis of vacuolar myopathies in the NGS era","volume":"30","author":"Mair","year":"2020","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1750-3639.2011.00543.x","article-title":"Autophagy in lysosomal myopathies","volume":"22","author":"Malicdan","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in\u00a0vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2022.05.003_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10741-016-9557-4","article-title":"Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy","volume":"21","author":"Fordjour","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ajpath.2022.05.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202114434","article-title":"Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease","volume":"13","author":"Tarallo","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2022.05.003_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1050-1738(00)00075-X","article-title":"How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes","volume":"10","author":"Alderton","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2022.05.003_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-010-0732-8","article-title":"High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation","volume":"120","author":"Ishigaki","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ymgme.2012.09.011","article-title":"Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease","volume":"107","author":"Nishiyama","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajpath.2022.05.003_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/cdd.2009.16","article-title":"Role of BNIP3 and NIX in cell death, autophagy, and mitophagy","volume":"16","author":"Zhang","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2022.05.003_bib48","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1073\/pnas.202474099","article-title":"Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family\u00a0protein BNIP3","volume":"99","author":"Kubasiak","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2022.05.003_bib49","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.bbamcr.2015.02.022","article-title":"Mitochondrial autophagy: origins, significance, and role of BNIP3 and NIX","volume":"1853","author":"Ney","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2022.05.003_bib50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1101\/gad.276725.115","article-title":"Inactivation of prosurvival Bcl-2 proteins activates Bax\/Bak through the outer mitochondrial membrane","volume":"30","author":"O'neill","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2022.05.003_bib51","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1074\/jbc.275.2.1439","article-title":"BNIP3 heterodimerizes with Bcl-2\/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites","volume":"275","author":"Ray","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2022.05.003_bib52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41418-017-0025-z","article-title":"New insights into apoptosome structure and function","volume":"25","author":"Dorstyn","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2022.05.003_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biochi.2017.02.001","article-title":"Apaf-1: regulation and function in cell death","volume":"135","author":"Shakeri","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.ajpath.2022.05.003_bib54","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.M800102200","article-title":"Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2022.05.003_bib55","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1096\/fj.01-0206fje","article-title":"The mitochondrial permeability transition initiates autophagy in rat hepatocytes","volume":"15","author":"Elmore","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2022.05.003_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062850","article-title":"Muscle proteomic profile before and after enzyme replacement therapy in late-onset Pompe disease","volume":"22","author":"Moriggi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2022.05.003_bib57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/nan.12034","article-title":"Muscle atrophy in limb girdle muscular dystrophy 2A: a morphometric and molecular study","volume":"39","author":"Fanin","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mus.24167","article-title":"Muscle atrophy, ubiquitin-proteasome, and autophagic pathways in dysferlinopathy","volume":"50","author":"Fanin","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2022.05.003_bib59","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1038\/cddis.2012.159","article-title":"Autophagy as a new therapeutic target in Duchenne muscular dystrophy","volume":"3","author":"De Palma","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2022.05.003_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/nan.12684","article-title":"Protein homeostasis in LGMDR9 (LGMD2I) \u2013 the role of ubiquitin\u2013proteasome and autophagy\u2013lysosomal system","volume":"47","author":"Franekova","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2022.05.003_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41420-018-0104-z","article-title":"Misoprostol regulates Bnip3 repression and alternative splicing to control cellular calcium homeostasis during hypoxic stress","volume":"4","author":"Field","year":"2018","journal-title":"Cell Death Discov"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:41:50Z","timestamp":1757695310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944022001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0002944022001468"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.05.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}